Drug and Alcohol Dependence

Editorial Board
pp. CO2-CO2(1)

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement
pp. 215-232(18)
Authors: Zacny J.; Bigelow G.; Compton P.; Foley K.; Iguchi M.; Sannerud C.

Physical dependence on Ultram⁽R) (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur
pp. 233-241(9)
Authors: Senay E.C.; Adams E.H.; Geller A.; Inciardi J.A.; Munoz A.; Schnoll S.H.; Woody G.E.; Cicero T.J.

Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS)
pp. 243-251(9)
Authors: Friedmann P.D.; Lemon S.C.; Anderson B.J.; Stein M.D.

The association between parental alcohol-related behaviors and children's drinking
pp. 253-262(10)
Author: Yu J.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection
pp. 263-272(10)
Authors: Umbricht A.; Hoover D.R.; Tucker M.J.; Leslie J.M.; Chaisson R.E.; Preston K.L.

Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine
pp. 273-282(10)
Authors: Sofuoglu M.; Dudish-Poulsen S.; Brown S.B.; Hatsukami D.K.

Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results
pp. 283-288(6)
Authors: Bochud Tornay C.; Favrat B.; Monnat M.; Daeppen J.B.; Schnyder C.; Bertschy G.; Besson J.

Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement
pp. 289-301(13)
Authors: Donny E.C.; Bigelow G.E.; Walsh S.L.

Early-onset cannabis use and cognitive deficits: what is the nature of the association?
pp. 303-310(8)
Authors: Pope H.G.; Gruber A.J.; Hudson J.I.; Cohane G.; Huestis M.A.; Yurgelun-Todd D.

Prevalence and correlates of areca nut use among psychiatric patients in India
pp. 311-316(6)
Authors: Chandra P.S.; Carey M.P.; Carey K.B.; Jairam K.R.

Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine
pp. 317-322(6)
Authors: Lopatko O.V.; White J.M.; Huber A.; Ling W.

Volume contents
pp. 325-326(2)